Funding opportunity

2000 ◽  
Author(s):  
Keyword(s):  
Funding Opportunity

Hustling for Funding

2021 ◽  
pp. 85-94
Author(s):  
Rob Kitchin
Keyword(s):  
Life Cycle ◽  
Open Data ◽  
Digital Repository ◽  
Funding Mechanism ◽  
Institutional Politics ◽  
Full Circle ◽  
Data Life Cycle ◽  
Funding Issue ◽  
Funding Opportunity

This chapter focuses on the role of finance and the politics of collaboration, charting the development of the Digital Repository of Ireland (DRI). DRI have been beset with institutional politics concerning its framing, development, and operation. The future funding issue was just the latest example in a long list of fraught exchanges that could be traced back to its original conception and funding mechanism. The DRI was born out of a funding opportunity, but seemed destined to die due to a funding failure. Without a political solution, the data life cycle would turn full circle much more quickly than initially anticipated. Unless there is a means of covering the costs for labour, equipment and other essential inputs, data are not generated or stored, and thus cannot be used or shared. Even in open data projects, the data might be free to use but they were not free to create, or to process and host.

scholarly journals Opportunities for strengthening CTSA evaluation

2019 ◽  
Vol 3 (2-3) ◽  
pp. 59-64 ◽  
Author(s):  
Tanha Patel ◽  
Julie Rainwater ◽  
William M. Trochim ◽  
Julie T. Elworth ◽  
Linda Scholl ◽  
...  
Keyword(s):  
National Level ◽  
Translational Science ◽  
Multiple Stakeholders ◽  
Significant Interest ◽  
Program Funding ◽  
The Common ◽  
Collaborative Evaluation ◽  
Funding Opportunity ◽  
Existing Data

AbstractThe purpose of the article is to describe the progress of the Clinical and Translational Science Award (CTSA) Program to address the evaluation-related recommendations made by the 2013 Institute of Medicine’s review of the CTSA Program and guidelines published in CTS Journal the same year (Trochim et al., Clinical and Translational Science 2013; 6(4): 303–309). We utilize data from a 2018 national survey of evaluators administered to all 64 CTSA hubs and a content analysis of the role of evaluation in the CTSA Program Funding Opportunity Announcements to document progress. We present four new opportunities for further strengthening CTSA evaluation efforts: (1) continue to build the collaborative evaluation infrastructure at local and national levels; (2) make better use of existing data; (3) strengthen and augment the common metrics initiative; and (4) pursue internal and external opportunities to evaluate the CTSA program at the national level. This article will be of significant interest to the funders of the CTSA Program and the multiple stakeholders in the larger consortium and will promote dialog from the broad range of CTSA stakeholders about further strengthening the CTSA Program’s evaluation.

scholarly journals NIH Funding of COVID-19 Research in 2020: a Cross Sectional Study

2021 ◽  
Author(s):  
Logesvar Balaguru ◽  
Chen Dun ◽  
Andrea Meyer ◽  
Sanuri Hennayake ◽  
Christi M. Walsh ◽  
...  
Keyword(s):  
Cross Sectional Study ◽  
Secondary Outcome ◽  
First Year ◽  
Sectional Study ◽  
Future Health ◽  
Cross Sectional ◽  
Allocation Pattern ◽  
Nih Funding ◽  
Funding Opportunity ◽  
Pharmaceutical Interventions

AbstractObjectiveThis study aims to characterize and evaluate the NIH’s grant allocation pattern of COVID-19 research.DesignCross sectional studySettingCOVID-19 NIH RePORTER Dataset was used to identify COVID-19 relevant grants.Participants1,108 grants allocated to COVID-19 research.Main Outcomes and MeasuresThe primary outcome was to determine the number of grants and funding amount the NIH allocated for COVID-19 by research type and clinical/scientific area. The secondary outcome was to calculate the time from the funding opportunity announcement to the award notice date.ResultsThe NIH awarded a total of 56,169 grants in 2020, of which 2.0% (n=1,108) were allocated for COVID-19 research. The NIH had a $42 billion budget that year, of which 5.3% ($2.2 billion) was allocated to COVID-19 research. The most common clinical/scientific areas were social determinants of health (n=278, 8.5% of COVID-19 funding), immunology (n=211, 25.8%), and pharmaceutical interventions research (n=208, 47.6%). There were 104 grants studying COVID-19 non-pharmaceutical interventions, of which 2 grants studied the efficacy of face masks and 6 studied the efficacy of social distancing. Of the 83 COVID-19 funded grants on transmission, 5 were awarded to study airborne transmission of COVID-19, and 2 grants on transmission of COVID-19 in schools. The average time from the funding opportunity announcement to the award notice date was 151 days (SD: ±57.9).ConclusionIn the first year of the pandemic, the NIH diverted a small fraction of its budget to COVID-19 research. Future health emergencies will require research funding to pivot in a timely fashion and funding levels to be proportional to the anticipated burden of disease in the population.

scholarly journals Impact-Driven Investing in New Mobility Enterprises: Perspectives from Kampala, Uganda, and Hyderabad, India

2021 ◽  
Author(s):  
Thet Hein Tun ◽  
Travis Fried ◽  
Chaitanya Kanuri ◽  
Anna Oursler ◽  
Adam Davidson ◽  
...  
Keyword(s):  
Sustainable Development Goals ◽  
Urban Residents ◽  
Impact Investing ◽  
The Sustainable Development ◽  
Political Risks ◽  
Environmentally Responsible ◽  
Private Investments ◽  
Development Goals ◽  
Holding Back ◽  
Funding Opportunity

Private investments present a critical funding opportunity to achieve the Sustainable Development Goals, due to the growing recognition that socially and environmentally responsible solutions can generate impacts and financial returns across the risk spectrum. Innovative new mobility solutions—especially when driven by impact-oriented investments and enabled by inclusive policies—can be part of the solution for sustainable and equitable transport. The research paper features key insights on impact-driven investments in new mobility enterprises in Kampala, Uganda, and Hyderabad, India. The paper highlights the current challenges to impact investing in mobility enterprises, including difficulties in accounting for impact, dilution of impact from other sectors, regulatory regimes and political risks that could hinder the running of mobility businesses, and entrenched stakeholders holding back investments. It concludes with opportunities to confront these challenges and pathways to safe, clean and inclusive transportation for vulnerable urban residents in the global south.

Sign in / Sign up

Export Citation Format

Share Document